Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Interferon-β in Moderate-to-Severe Hospitalised Cases of COVID-19: A Systematic Review and Meta-analysis
Subodh Kumar, Manoj Kumar Saurabh, Venkata Lakshmi Narasimha, et al.
Clinical Drug Investigation (2021) Vol. 41, Iss. 12, pp. 1037-1046
Open Access | Times Cited: 9

Showing 9 citing articles:

Efficacy of interferon alpha for the treatment of hospitalized patients with COVID-19: A meta-analysis
Mykhailo Buchynskyi, Iryna Kamyshna, Katerina Lyubomirskaya, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Seungeun Ryoo, Dae-Hyup Koh, Su‐Yeon Yu, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0272826-e0272826
Open Access | Times Cited: 17
The value of Interferon β in multiple sclerosis and novel opportunities for its anti-viral activity: a narrative literature review
Gianmarco Bellucci, Angela Albanese, Caterina Rizzi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Cysteamine-mediated blockade of the glycine cleavage system modulates epithelial cell inflammatory and innate immune responses to viral infection
Douglas Fraser‐Pitt, Derry K. Mercer, Marie-Louise Francis, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 677, pp. 168-181
Open Access | Times Cited: 5
Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4
The Safety and Efficacy of the Protease Inhibitors Lopinavir/Ritonavir as Monotherapy or Combined with Interferon in COVID-19 Patients
Mahmoud Kandeel, Mohamed A. Morsy, Hany M. Abd El‐Lateef, et al.
Processes (2023) Vol. 11, Iss. 2, pp. 398-398
Open Access | Times Cited: 1
Outpatient medications associated with protection from COVID-19 hospitalization
Harpal S. Sandhu, Joshua Lambert, Zach Steckler, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282961-e0282961
Open Access | Times Cited: 1
Systemic Review and Meta-Analysis to Evaluate Therapeutic Effectiveness of Interferon Beta-1b in Hospitalized COVID-19 Patients
Greeshma Sai Sree Nayudu, Mamkoottathil Benny, Grace M. Thomas, et al.
Indian Journal of Community Medicine (2023) Vol. 48, Iss. 3, pp. 390-400
Open Access
Impact of COVID-19 on Drug Discovery and Development: A Pharmacologist's Perspective
Dibyajyoti Saikia, Hansraj Kumar, Subodh Kumar
Advanced Biomedical Research (2023) Vol. 12, Iss. 1
Open Access
Page 1

Scroll to top